KPC Pharmaceuticals Inc
SSE:600422

Watchlist Manager
KPC Pharmaceuticals Inc Logo
KPC Pharmaceuticals Inc
SSE:600422
Watchlist
Price: 17.03 CNY -1.73% Market Closed
Market Cap: 12.9B CNY
Have any thoughts about
KPC Pharmaceuticals Inc?
Write Note

KPC Pharmaceuticals Inc
Change in Working Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

KPC Pharmaceuticals Inc
Change in Working Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Change in Working Capital CAGR 3Y CAGR 5Y CAGR 10Y
KPC Pharmaceuticals Inc
SSE:600422
Change in Working Capital
-ÂĄ2.3B
CAGR 3-Years
9%
CAGR 5-Years
4%
CAGR 10-Years
-12%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Change in Working Capital
-ÂĄ332.3m
CAGR 3-Years
26%
CAGR 5-Years
1%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Change in Working Capital
-ÂĄ1.1B
CAGR 3-Years
23%
CAGR 5-Years
-59%
CAGR 10-Years
-16%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Change in Working Capital
-ÂĄ16.8B
CAGR 3-Years
4%
CAGR 5-Years
-4%
CAGR 10-Years
-14%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Change in Working Capital
-ÂĄ5.2B
CAGR 3-Years
-1%
CAGR 5-Years
2%
CAGR 10-Years
-7%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Change in Working Capital
-ÂĄ1.1B
CAGR 3-Years
-13%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

KPC Pharmaceuticals Inc
Glance View

Market Cap
12.9B CNY
Industry
Pharmaceuticals

KPC Pharmaceuticals Inc., founded in 1951, has cultivated a strong presence in the pharmaceutical industry, rooted in the rich herbal traditions of China. With its headquarters strategically located in Yunnan, a region renowned for its vast biodiversity, KPC leverages this unique advantage by integrating indigenous herbal knowledge into modern pharmaceuticals. The company has carved a niche for itself primarily through the production and distribution of traditional Chinese medicine. This approach not only honors the cultural heritage of its origins but also allows the company to capitalize on a growing global demand for alternative and complementary medical treatments. The blend of traditional herbal medicine and cutting-edge pharmaceutical practices forms the backbone of its business model, enabling KPC to sustain substantial revenue through both local and international markets. Diversification is a cornerstone of KPC Pharmaceuticals' strategy. Beyond its traditional medicines, the company has aggressively pursued research and development in the biopharmaceutical sector. This move has expanded its product offerings to include chemical drugs, biotechnology, and over-the-counter products, broadening their appeal to a more extensive clientele. The continuous investment in R&D has led to the development of innovative treatments for ailments such as cardiovascular diseases, cancer, and other chronic illnesses. Additionally, KPC's robust sales network encompasses hospitals, pharmacies, and other healthcare institutions, ensuring widespread distribution and accessibility of its products. Through this diversified portfolio and strong distribution channels, KPC Pharmaceuticals continues to thrive by meeting the evolving needs of the healthcare industry while maintaining its commitment to quality and efficiency.

Intrinsic Value
24.27 CNY
Undervaluation 30%
Intrinsic Value
Price

See Also

What is KPC Pharmaceuticals Inc's Change in Working Capital?
Change in Working Capital
-2.3B CNY

Based on the financial report for Sep 30, 2024, KPC Pharmaceuticals Inc's Change in Working Capital amounts to -2.3B CNY.

What is KPC Pharmaceuticals Inc's Change in Working Capital growth rate?
Change in Working Capital CAGR 10Y
-12%

Over the last year, the Change in Working Capital growth was 16%. The average annual Change in Working Capital growth rates for KPC Pharmaceuticals Inc have been 9% over the past three years , 4% over the past five years , and -12% over the past ten years .

Back to Top